(Q43545273)

24 November 2017

FeNO measured at fixed exhalation flow rate during controlled tidal breathing in children from the age of 2 yr. (English)

1 reference

24 November 2017

1 reference

2

1 reference

24 November 2017

Buchvald F

1

1 reference

PubMed ID

11254527

24 November 2017

language of work or name

English

0 references

publication date

1 March 2001

1 reference

American Journal of Respiratory and Critical Care Medicine

24 November 2017

1 reference

24 November 2017

163

1 reference

24 November 2017

3 Pt 1

1 reference

24 November 2017

699-704

1 reference

A review of pulmonary function testing in children

24 November 2017

1 reference

https://api.crossref.org/works/10.1164%2FAJRCCM.163.3.2004233

Exhaled nitric oxide in paediatric asthma and cystic fibrosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FAJRCCM.163.3.2004233

Expired nitric oxide as a marker for childhood asthma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FAJRCCM.163.3.2004233

Increase in exhaled nitric oxide levels in patients with difficult asthma and correlation with symptoms and disease severity despite treatment with oral and inhaled corticosteroids. Asthma and Allergy Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FAJRCCM.163.3.2004233

Effect of natural grass pollen exposure on exhaled nitric oxide in asthmatic children.

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FAJRCCM.163.3.2004233

Expired nitric oxide levels during treatment of acute asthma

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FAJRCCM.163.3.2004233

Comparison of exhaled nitric oxide to spirometry during emergency treatment of asthma exacerbations with glucocorticoids in children

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FAJRCCM.163.3.2004233

Effect of differing doses of inhaled budesonide on markers of airway inflammation in patients with mild asthma

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FAJRCCM.163.3.2004233

Effect of inhaled steroids on airway hyperresponsiveness, sputum eosinophils, and exhaled nitric oxide levels in patients with asthma

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FAJRCCM.163.3.2004233

Exhaled and nasal nitric oxide measurements: recommendations. The European Respiratory Society Task Force.

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FAJRCCM.163.3.2004233

Exhaled nitric oxide concentrations during treatment of wheezing exacerbation in infants and young children.

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FAJRCCM.163.3.2004233

Exhalation flow and pressure-controlled reservoir collection of exhaled nitric oxide for remote and delayed analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FAJRCCM.163.3.2004233

Statistical methods for assessing agreement between two methods of clinical measurement

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FAJRCCM.163.3.2004233

Nasal contribution to exhaled nitric oxide during exhalation against resistance or during breath holding

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FAJRCCM.163.3.2004233

Effect of atmospheric nitric oxide (NO) on measurements of exhaled NO in asthmatic children.

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FAJRCCM.163.3.2004233

Effect of oral prednisone on airway inflammatory mediators in atopic asthma

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FAJRCCM.163.3.2004233

Measurements of exhaled nitric oxide with the single-breath technique and positive expiratory pressure in infants.

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FAJRCCM.163.3.2004233

A community study of exhaled nitric oxide in healthy children.

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FAJRCCM.163.3.2004233

Lung function measurement in awake young children.

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FAJRCCM.163.3.2004233

NO in Exhaled Air of Asthmatic Children Is Reduced by the Leukotriene Receptor Antagonist Montelukast

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FAJRCCM.163.3.2004233

Marked flow-dependence of exhaled nitric oxide using a new technique to exclude nasal nitric oxide

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FAJRCCM.163.3.2004233

10.1164/AJRCCM.163.3.2004233

21 January 2018

Identifiers

DOI

1 reference

24 November 2017

1 reference

PubMed ID

11254527